|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.04 EUR | -3.41% |
|
-1.51% | -2.40% |
| 01-16 | EVONIK : JP Morgan is Neutral | ZD |
| 01-16 | Chemical Stocks Under Pressure - Experts: Challenging Times Persist | DP |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.61 | 3.67 | 3.99 | 1.81 | 2.63 | |||||
Return on Total Capital | 4.37 | 6.3 | 6.17 | 2.66 | 3.99 | |||||
Return On Equity % | 5.86 | 8.8 | 5.42 | -4.51 | 2.65 | |||||
Return on Common Equity | 5.76 | 8.65 | 5.32 | -4.68 | 2.48 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 27.59 | 27.2 | 23.51 | 22.21 | 25.79 | |||||
SG&A Margin | 16.39 | 15.07 | 13.88 | 15.17 | 17.31 | |||||
EBITDA Margin % | 14.32 | 14.37 | 12.82 | 11.75 | 11.18 | |||||
EBITA Margin % | 8.51 | 9.54 | 8.49 | 4.95 | 6.41 | |||||
EBIT Margin % | 7.34 | 8.49 | 7.62 | 3.97 | 5.5 | |||||
Income From Continuing Operations Margin % | 4.12 | 5.14 | 3 | -2.96 | 1.58 | |||||
Net Income Margin % | 3.81 | 4.99 | 2.92 | -3.05 | 1.46 | |||||
Net Avail. For Common Margin % | 4.01 | 5 | 2.92 | -3.05 | 1.46 | |||||
Normalized Net Income Margin | 3.77 | 4.78 | 4.57 | 1.62 | 2.67 | |||||
Levered Free Cash Flow Margin | 5.08 | 5.12 | 1.94 | 7.32 | 4.65 | |||||
Unlevered Free Cash Flow Margin | 5.96 | 5.66 | 2.36 | 8.32 | 5.53 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.57 | 0.69 | 0.84 | 0.73 | 0.76 | |||||
Fixed Assets Turnover | 1.95 | 2.4 | 2.76 | 2.27 | 2.37 | |||||
Receivables Turnover (Average Receivables) | 8.03 | 8.75 | 9.59 | 8.7 | 9.38 | |||||
Inventory Turnover (Average Inventory) | 4.79 | 5 | 5.27 | 4.6 | 4.49 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.7 | 1.53 | 1.83 | 1.46 | 1.36 | |||||
Quick Ratio | 0.93 | 0.77 | 0.93 | 0.77 | 0.65 | |||||
Operating Cash Flow to Current Liabilities | 0.59 | 0.45 | 0.45 | 0.39 | 0.42 | |||||
Days Sales Outstanding (Average Receivables) | 45.57 | 41.7 | 38.05 | 41.95 | 39.02 | |||||
Days Outstanding Inventory (Average Inventory) | 76.45 | 72.99 | 69.27 | 79.43 | 81.53 | |||||
Average Days Payable Outstanding | 54.28 | 51.71 | 47.57 | 52.1 | 49.4 | |||||
Cash Conversion Cycle (Average Days) | 67.74 | 62.97 | 59.76 | 69.28 | 71.15 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 48.55 | 40.11 | 39.05 | 47.26 | 41.55 | |||||
Total Debt / Total Capital | 32.68 | 28.63 | 28.08 | 32.09 | 29.35 | |||||
LT Debt/Equity | 44.01 | 37.63 | 36.85 | 36.67 | 32.35 | |||||
Long-Term Debt / Total Capital | 29.62 | 26.86 | 26.5 | 24.9 | 22.86 | |||||
Total Liabilities / Total Assets | 61.24 | 57.94 | 49.31 | 54.93 | 53.92 | |||||
EBIT / Interest Expense | 5.23 | 9.84 | 11.54 | 2.48 | 3.93 | |||||
EBITDA / Interest Expense | 11.04 | 17.75 | 20.66 | 8.08 | 8.82 | |||||
(EBITDA - Capex) / Interest Expense | 5.45 | 10.88 | 13.57 | 4.83 | 4.86 | |||||
Total Debt / EBITDA | 2.08 | 1.64 | 1.71 | 2.15 | 2.02 | |||||
Net Debt / EBITDA | 1.52 | 1.24 | 1.27 | 1.63 | 1.69 | |||||
Total Debt / (EBITDA - Capex) | 4.22 | 2.68 | 2.61 | 3.6 | 3.67 | |||||
Net Debt / (EBITDA - Capex) | 3.08 | 2.02 | 1.93 | 2.73 | 3.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.93 | 22.59 | 23.62 | -17.42 | -0.72 | |||||
Gross Profit, 1 Yr. Growth % | -8.9 | 21.69 | 6.83 | -21.61 | 15.28 | |||||
EBITDA, 1 Yr. Growth % | -12.17 | 25.6 | 9.98 | -23.1 | -5.57 | |||||
EBITA, 1 Yr. Growth % | -21.9 | 42.32 | 9.64 | -50.68 | 28.27 | |||||
EBIT, 1 Yr. Growth % | -25.04 | 47.73 | 10.43 | -55.8 | 37.4 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -35.01 | 52.88 | -27.96 | -181.59 | -153.1 | |||||
Net Income, 1 Yr. Growth % | -77.92 | 60.43 | -27.61 | -186.11 | -147.74 | |||||
Normalized Net Income, 1 Yr. Growth % | -27.95 | 63.2 | 17.54 | -69.85 | 62.94 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -35.06 | 52.97 | -27.94 | -186.27 | -147.74 | |||||
Accounts Receivable, 1 Yr. Growth % | -7.11 | 33.56 | -2.71 | -15.41 | 1 | |||||
Inventory, 1 Yr. Growth % | -4.14 | 41.09 | 10.68 | -16.7 | 13.32 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.67 | 1.98 | 13.13 | -10.69 | 1.78 | |||||
Total Assets, 1 Yr. Growth % | -5.11 | 6.64 | -2.13 | -8.57 | -0.95 | |||||
Tangible Book Value, 1 Yr. Growth % | -31.41 | 52.81 | 61.83 | -35.63 | 1.82 | |||||
Common Equity, 1 Yr. Growth % | -10.68 | 15.94 | 18.14 | -18.81 | 1.23 | |||||
Cash From Operations, 1 Yr. Growth % | 30.73 | 5.1 | -9.09 | -3.39 | 7.47 | |||||
Capital Expenditures, 1 Yr. Growth % | 8.64 | -7.32 | -2.37 | -8.32 | 5.93 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -3.18 | 28.55 | -53.35 | 182.83 | -36.94 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -6.63 | 20.47 | -48.81 | 169.44 | -34.08 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 1.74 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -4.11 | 6.81 | 23.11 | 1.04 | -9.46 | |||||
Gross Profit, 2 Yr. CAGR % | -8.22 | 4.93 | 14.02 | -8.7 | -4.94 | |||||
EBITDA, 2 Yr. CAGR % | -8.31 | 3.94 | 17.69 | -8.76 | -14.76 | |||||
EBITA, 2 Yr. CAGR % | -15.71 | 3.59 | 25.17 | -27.34 | -20.41 | |||||
EBIT, 2 Yr. CAGR % | -17.91 | 3.09 | 28.03 | -31.06 | -22.01 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -15.71 | -0.32 | 4.95 | -23.33 | -34.18 | |||||
Net Income, 2 Yr. CAGR % | -29.37 | -40.48 | 7.76 | -21.05 | -35.88 | |||||
Normalized Net Income, 2 Yr. CAGR % | -19.15 | 5.75 | 38.86 | -41.29 | -29.82 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -15.57 | -0.33 | 4.99 | -21.15 | -35.82 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.99 | 11.38 | 13.99 | -9.28 | -7.57 | |||||
Inventory, 2 Yr. CAGR % | -11.46 | 16.29 | 24.96 | -3.98 | -2.84 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 5.01 | -0.37 | 7.41 | 0.52 | -4.66 | |||||
Total Assets, 2 Yr. CAGR % | 1.5 | 0.59 | 2.16 | -5.41 | -4.84 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.69 | 2.38 | 57.25 | 2.06 | -19.04 | |||||
Common Equity, 2 Yr. CAGR % | 1.81 | 1.76 | 17.03 | -2.06 | -9.34 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.94 | 17.22 | -2.25 | -6.29 | 1.89 | |||||
Capital Expenditures, 2 Yr. CAGR % | 0.42 | 0.34 | -4.88 | -5.39 | -1.46 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 12.6 | 9.43 | -22.37 | 20.46 | 33.59 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 8.8 | 4.33 | -21.3 | 22.18 | 33.31 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0.87 | 0.87 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -5.34 | 4.07 | 12.15 | 7.76 | 0.45 | |||||
Gross Profit, 3 Yr. CAGR % | -9.08 | 0.6 | 5.56 | 0.48 | -1.32 | |||||
EBITDA, 3 Yr. CAGR % | -7.24 | 1.13 | 6.02 | 1.59 | -7.69 | |||||
EBITA, 3 Yr. CAGR % | -11.21 | -0.8 | 5.71 | -8.96 | -12.15 | |||||
EBIT, 3 Yr. CAGR % | -13.02 | -1.5 | 5.65 | -10.98 | -13.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -11.68 | 2.79 | -10.55 | -3.5 | -32.17 | |||||
Net Income, 3 Yr. CAGR % | -13.28 | -7.15 | -36.47 | 0 | -33.24 | |||||
Normalized Net Income, 3 Yr. CAGR % | -12.51 | 0.49 | 9.73 | -17.3 | -17.42 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -11.81 | 2.93 | -10.55 | -1.66 | -33.3 | |||||
Accounts Receivable, 3 Yr. CAGR % | -5.92 | 4.94 | 6.47 | 3.2 | -5.98 | |||||
Inventory, 3 Yr. CAGR % | -3.95 | 3.41 | 14.39 | 9.16 | 1.47 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 3.86 | 3.99 | 3.94 | 1 | 0.94 | |||||
Total Assets, 3 Yr. CAGR % | 1.57 | 3.19 | -0.32 | -1.55 | -3.94 | |||||
Tangible Book Value, 3 Yr. CAGR % | 17.2 | 26.93 | 19.26 | 16.76 | 1.98 | |||||
Common Equity, 3 Yr. CAGR % | 2.54 | 6.32 | 6.95 | 3.6 | -0.97 | |||||
Cash From Operations, 3 Yr. CAGR % | 3.65 | 1.03 | 7.69 | -2.64 | -1.91 | |||||
Capital Expenditures, 3 Yr. CAGR % | -2.77 | -2.23 | -0.57 | -6.04 | -1.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 24.79 | 16.17 | -17.51 | 23.3 | -2.9 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.56 | 11.33 | -17.59 | 21.79 | -0.52 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 0.58 | 0.58 | 0.58 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -2.02 | 3.27 | 5.15 | 2.85 | 2.95 | |||||
Gross Profit, 5 Yr. CAGR % | -5.26 | -0.63 | -0.6 | -3.23 | 1.13 | |||||
EBITDA, 5 Yr. CAGR % | -6.16 | 0.19 | 1.6 | -2.9 | -3.15 | |||||
EBITA, 5 Yr. CAGR % | -9.77 | -0.51 | 1.15 | -12.35 | -6.08 | |||||
EBIT, 5 Yr. CAGR % | -12.02 | -2.24 | 0.7 | -14.52 | -6.93 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -13.17 | 0.18 | -5.37 | -8.58 | -20.88 | |||||
Net Income, 5 Yr. CAGR % | -14.04 | -2.44 | -5.41 | -12.98 | -36.24 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.13 | -0.16 | 4.2 | -18.86 | -8.74 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -13.47 | 0 | -5.44 | -7.48 | -21.67 | |||||
Accounts Receivable, 5 Yr. CAGR % | -4.2 | 3.3 | 1.59 | -1 | 0.61 | |||||
Inventory, 5 Yr. CAGR % | 0.48 | 8.7 | 6.71 | 0.39 | 7.16 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.29 | 3.66 | 5.26 | 2.59 | 0.41 | |||||
Total Assets, 5 Yr. CAGR % | 4.21 | 2.55 | 1.81 | -0.34 | -2.16 | |||||
Tangible Book Value, 5 Yr. CAGR % | -13.17 | -5.58 | 31.82 | 16.33 | 2.14 | |||||
Common Equity, 5 Yr. CAGR % | 1.35 | 3.94 | 8.11 | 2.88 | 0.11 | |||||
Cash From Operations, 5 Yr. CAGR % | -2.61 | 0.51 | 1.25 | -1.96 | 5.33 | |||||
Capital Expenditures, 5 Yr. CAGR % | 0.86 | -1.34 | -3.62 | -3.51 | -0.93 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -9.58 | 13.64 | 2.41 | 17.99 | 1.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -9.22 | 9.12 | -1.55 | 15.65 | 1.48 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0 | 0.35 | 0.35 | 0.35 | 0.35 |
- Stock Market
- Equities
- EVK Stock
- Financials Evonik Industries AG
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















